Compare Acadia Healthcare Company Inc (ACHC) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acadia Healthcare Company Inc vs 22nd Century Group Inc — how do they compare? Acadia Healthcare Company Inc trades at $31.18 (market cap $2.90B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Acadia Healthcare Company Inc is far larger — about 1907.9× 22nd Century Group Inc's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| ACHC | XXII | |
|---|---|---|
Market Cap | $2.90B | $1.52M |
Sector | Health | Technology |
52-Week High | $35.61 | $801.00 |
52-Week Low | $11.68 | $3.72 |
Enterprise Value | $5.29B | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.70, down 0.25% on the day, with neutral technical indicators and strong analyst support (68% buy ratings). The company has beaten earnings estimates for three consecutive quarters, though profitability remains challenged with a -33.44% net income margin. Recent Q2 2026 results showed revenue of $865.8 million with earnings beating expectations at $0.38 per share.
While facing profitability challenges and ongoing legal investigations, ACHC benefits from strong analyst consensus with a $36.00 price target representing 13.6% upside. The stock offers potential through continued earnings beats and operational improvements, but investors must weigh legal risks against the company's turnaround strategy and behavioral healthcare demand growth.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
